$ZION

MCLEAN SCOTT J sold $3.6M of ZION

MCLEAN SCOTT J (President) sold 51,285 shares of ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/ (ZION) at an average of $70.60 ($70.56–$70.63, $3.62M total) across 3 trades over 2026-08-03 to 2026-08-04.

Original reporting
SEC EDGAR · MCLEAN SCOTT J
Published Aug 5, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 6:25 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ZION
Neutral
medium confidence
Mentioned
$ZION
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ZIONNeutralLow
01

Why it matters

The newest fact is the disclosed open-market sale by the company’s President, including trade dates, share count, and total value.

02

Market read

Traders may note the insider selling activity, but there is no accompanying fundamental update in the text.

03

What to watch

The article does not state whether the sale was part of a broader compensation or tax strategy, nor does it provide subsequent insider buying or changes in overall insider ownership beyond the post-transaction holdings.

Relevance 6/10Novelty 3/10Timing: Filed 2026-08-05 for sales executed 2026-08-03 to 2026-08-04.

Background

The article is an SEC Form 4 insider transaction disclosure for Zions Bancorporation, National Association (UT).

Company-level read

Ticker impact

$ZIONNeutralMedium confidence
Context

Zions Bancorporation insider sale: President McLean Scott J sold $3.62M of ZION shares in open-market trades at about $70.60.

Expected impact

Low likelihood of sustained price impact; any effect is likely limited to short-term sentiment around insider activity.

Evidence & confidence

The filing is a Form 4 insider transaction with disclosed sale size and price range, but it does not include new company fundamentals, guidance, or regulatory/operational developments.

Market effects

Banking sector read-through is minimal because this is a single-insider transaction without new sector-wide information.

No clear regional market linkage beyond general bank sentiment.

Limited global relevance; this is company-specific insider trading disclosure.

Counterpoint

Insider sales can be driven by diversification, taxes, or pre-planned liquidity needs, so the signal may be overstated versus the lack of a disclosed 10b5-1 plan.

Key entities

  • Zions Bancorporation, National Association (UT)

    Subject of the Form 4 insider transaction disclosure.

  • MCLEAN SCOTT J

    President of Zions Bancorporation; sold 51,285 shares for about $3.62M.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ZIONMed

Zions (ZION) Q3 2026 Earnings Call Transcript

Zions (ZION) reported Q3 2026 net interest margin at 3.23%, down from prior periods. Loans grew 3.7% annualized, deposits 8.8%. Adjusted pre-provision net revenue was $338M, up 2% QoQ. The company acquired a multifamily agency lending business, expecting $17M-$20M revenue in 2027. Wealth management and strategic products drive growth. Net interest income rose 1% QoQ to $684M, but margin declined due to higher deposit costs.

$ZIONMed

TD Cowen reiterates Hold rating on Zions Bancorp, $69 price target

TD Cowen maintained a Hold rating on Zions Bancorp with a $69 price target, implying a 298.8% upside from the Oct 19 close of $17.30. The bank's recent earnings missed expectations due to weaker net interest income and higher expenses, raising concerns about growth and execution risk. Loan growth guidance is modest, and the bank relies on net interest margin expansion for income.

$ZIONMed

DA Davidson raises Zions Bancorp stock price target on earnings beat

DA Davidson raised its price target for Zions Bancorp (ZION) to $80 from $79, citing an earnings beat driven by provision benefits. The bank reported core EPS of $1.73, exceeding forecasts. ZION trades at a P/E of 8.05 and PEG of 0.17. Six analysts revised earnings upwards. The bank projects 8%-12% net interest income growth. Q3 2026 EPS was $1.78, beating estimates, but revenue missed forecasts. Jefferies lowered its target to $75.

$ZIONMed

Jefferies cuts Zions Bancorp stock price target on NII miss

Jefferies reduced Zions Bancorp's (ZION) price target to $75 from $80, citing a net interest income (NII) miss, though it maintained a Buy rating. ZION reported core EPS of $1.77, beating estimates, but core pre-provision net revenue missed expectations. The stock has a P/E ratio of 8.05 and a PEG ratio of 0.19, suggesting undervaluation. ZION guided for 8-12% NII growth over the next 12 months and a mid-3% net interest margin by 2027.

$ZIONHighAI 8/10

Zions Bancorp NA (ZION) (Q3 2026) Earnings Call Highlights: Earnings Jump 20% as Deposits

Zions Bancorp (ZION) reported Q3 2026 earnings up 20%, driven by deposit growth. Net interest margin fell 4 basis points sequentially. Full-year 2026 operating leverage guidance was cut to 40-50 basis points. Loan growth outlook was reduced to 2-4% for Q3 2027, with caution on commercial real estate. Deposit costs are expected to rise to 2%. The company anticipates $17-20M revenue from the Basis acquisition in 2027. Share buybacks may increase, subject to regulatory approval.

$ZIONMed

Zions Bancorporation Q3 Earnings Improve

Zions Bancorporation reported Q3 2026 earnings per share rose 20% to $1.78, driven by improved credit quality. Net income increased to $262M from $221M YoY. Non-interest income and net interest income also grew, while total interest income declined slightly.